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CytotoxicityPiper gaudichaudianum Kunth is used in popular medicine as anti-inﬂamatory and against liver disorders.
One of the most studied components of the plant is the essential oil for which chemical analysis revealed
(E)-nerolidol as major compound. Recently, we have shown that P. gaudichaudianum essential oil pos-
sesses strong cytotoxic effects in mammalian V79 cells. The aim of this study was to analyze the cytotox-
icity and mutagenicity of P. gaudichaudianum essential oil and nerolidol using Saccharomyces cerevisiae as
model study. Treatment of the XV185-14c and N123 strains with essential oil and nerolidol led to cyto-
toxicity but did not induce mutagenicity. Our results revealed an important role of base excision repair
(BER) as the ntg1, ntg2, apn1 and apn2 mutants showed pronounced sensitivity to essential oil and ner-
olidol. In the absence of superoxide dismutase (in sod1Dmutant strain) sensitivity to the essential oil and
nerolidol increased indicating that this oil and nerolidol are generating reactive oxygen species (ROS). The
ROS production was conﬁrmed by DCF-DA probing assay in Sod-deﬁcient strains. From this, we conclude
that the observed cytotoxicity to P. gaudichaudianum essential oil and nerolidol is mainly related to ROS
and DNA single strand breaks generated by the presence of oxidative lesions.
 2013 Elsevier Ltd. Open access under the Elsevier OA license. 1. Introduction employed in folk medicine as analgesics for pain management,Piper gaudichaudianum Kunth is a plant that belongs to the Pip-
eraceae family. This family is composed of 7 genera and approxi-
mately 1100 species. The genus Piper (Piperaceae) is well known
for its aromatic herbs, which are largely distributed in tropical
and subtropical regions of the world. Some Piper species are alsotoothaches and wound treatment (Guerrini et al., 2009). P. gaudi-
chaudianum Kunth is widely distributed in the Brazilian Atlantic
forest, from the Northeast to southern of Brazil, and reaching
Argentina and Paraguay. This plant is popularly known by the
names ‘‘Iaborandi’’, ‘‘Jaborandi’’, ‘‘Paripaioba’’ and ‘‘Pariparoba’’
(Di Stasi and Hiruma-Lima, 2002).
According to popular medicine, the leaves infusion and fresh
leaves of P. gaudichaudianum are used to relieve toothache, while
the fresh roots are used as anti-inﬂammatory and against liver dis-
orders (Di Stasi and Hiruma-Lima, 2002). Other previously de-
scribed biological activities using different plant material from
this species include fungicidal and larvicidal effects (Lago et al.,
2004; Morais et al., 2007) as well as anti-inﬂammatory and analge-
sic activities of leaf extracts (Di Stasi and Hiruma-Lima, 2002;
Moreira et al., 2001). Furthermore, the essential oil of P. gaudichau-
dianum leaves has anti-inﬂammatory and larvicidal activity (Mor-
ais et al., 2007). We have recently demonstrated that this
essential oil has strong cytotoxic, genotoxic and mutagenic effects
in mammalian V79 cells, and these effects are likely related to its
oxidative potential (Péres et al., 2009).
The previously published studies on P. gaudichaudianum have
presented analyses of its leaves and its essential oil phytochemical
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constituent compounds. Among the terpenes identiﬁed were (E)-
nerolidol, d-limonene, linalool, b-caryophyllene, a-humulene and
cymene (Andrade et al., 1998; Péres et al., 2009; Poser et al.,
1994; Rorig and Poser, 1991).
(E)-nerolidol, one of the major sesquiterpenes present in the
essential oil of P. gaudichaudianum that was identiﬁed previously
by our research group (Péres et al., 2009), is used to enhance ﬂavor
and aroma, is approved by the U.S. Food and Drug Administration,
and has been studied as a topical skin penetration enhancer for the
transdermal delivery of therapeutic drugs (Lapczynski et al., 2008;
Williams and Barry, 2004). Studies related to the biological activity
of nerolidol showed an antifungal effect against Microsporum gyp-
seum (Lee et al., 2007), activity against L3 larvae of Anisakis type I
(Navarro-Moll et al., 2011), and antimalarial (Lopes et al., 1999),
antileishmanial and antiulcer activities (Arruda et al., 2005; Klopell
et al., 2007). In addition, (E)-nerolidol and a-humulene have been
shown to be cytotoxic on renal cell adenocarcinoma ACHN, the
hormone-dependent prostate carcinoma LNCaP, the amelanotic
melanoma C32 and the MCF-7 breast cancer cell line (Legault
et al., 2003; Loizzo et al., 2007a,b; Sylvestre et al., 2007).
In view of the absence of knowledge about the exact cytotoxic
mechanisms of P. gaudichaudianum essential oil, the aim of the
present study was to investigate the cytotoxic effects of the essen-
tial oil and compound nerolidol (a racemic mixture of cis and trans
isomers) using Saccharomyces cerevisiae strains deﬁcient in the ma-
jor DNA repair proteins. Induced mutagenesis was also tested in
the haploid XV185-14c and N123 S. cerevisiae strains. The oxidative
potential of the essential oil and nerolidol was also estimated by
cytotoxic assay with superoxide dismutase and catalase yeast deﬁ-
cient strains and 20,70-dichloroﬂuorescein (DCF) ﬂuorescent assay,
which detects intracellular ROS generation. In addition, weTable 1
Saccharomyces cerevisiae strains used in this study. BER: base excision repair; NER: nucl
joining; TLS: translesion synthesis.
Strain Genotype
BY4741 (WT) MATa; his3D1; leu2D0; met15D0; ura3D
apn1D BY4741; with apn1::kanMX4
rad1D BY4741; with rad1::kanMX4
rad10D BY4741; with rad10::kanMX4
rad18D BY4741; with rad18::kanMX4
rad30D BY4741; with rad30::kanMX4
rad50D BY4741; with rad50::kanMX4
rad52D BY4741; with rad52::kanMX4
rev1D BY4741; with rev1::kanMX4
rev3D BY4741; with rev3::kanMX4
ku70D BY4741; with ku70::kanMX4
SJR751 (WT) MATa; ade2-101oc; his3D200; ura3DNco; lys2
ntg1D SJ751; with ntg1::LEU2
ntg2D SJ751; with ntg2::hisG
ntg1D ntg2D SJ751; with ntg1::LEU2 ntg2::hisG
ntg1D ntg2D apn1D SJ751; with ntg1::LEU2 ntg2::hisG apn1::HIS3
ntg1D ntg2D apn1D rad1D SJ751; with ntg1::LEU2 ntg2::hisG apn1::HIS3
ntg1D ntg2D apn1D rev3D SJ751; with ntg1::LEU2 ntg2::hisG apn1::HIS3
ntg1D ntg2D apn1D rad52D SJ751; with ntg1::LEU2 ntg2::hisG apn1::HIS3
EG103 (SOD-WT) MATa; leu2-3 112his3-D1 trp1-289 ura3-52
EG118 (sod1D) like EG103, except sod1::URA3
EG110 (sod2D) like EG103, except sod2::TRP1
EG133 (sod1D sod2D) like EG103, except sod1::URA3 e sod2::TRP1
EG223 (ctt1D) like EG103, except ctt1::TRP1
EG (sod1D ctt1D) like EG103, except sod1::URA3 e ctt1::TRP1
XV185-14c MATa; ade2-2; arg4-17; his1-7; lys1-1; trp5-4
N123 MATa; his1-7
a Strains obtained from Euroscarf, Frankfurt, Germany.
b RL Swanson, Atlanta, Georgia, USA.
c E Gralla, Los Angeles, California, USA.
d RC Von Borstel, Edmonton, Alberta, Canada.
e JAP Henriques, Porto Alegre, Rio Grande do Sul, Brazil.performed a more detailed chemical analysis of P. gaudichaudia-
num essential oil by comprehensive two dimensional gas chroma-
tography/time-of-ﬂight mass spectrometer analyses (GC  GC/
TOF-MS).
2. Materials and methods
2.1. Chemicals
Amino acids (L-histidine, L-threonine, L-methionine, L-tryptophan, L-leucine, L-
lysine, L-arginine), 4 nitroquinoline-oxide (4-NQO), hydrogen peroxide (H2O2), L-
canavanine, nitrogen bases (adenine and uracil), 20 ,70-dichloroﬂuorescein diacetate
(DCFH-DA) and dimethylsulfoxide (DMSO) were purchased from Sigma–Aldrich (St.
Louis, MO, USA). Yeast extract, bacto-peptone, bacto-agar, yeast nitrogen base with
no amino acids and glucose were acquired from Difco Laboratories (Detroit, MI,
USA). Nerolidol (a racemic mixture of cis and trans isomers) used in the analytical
and biological assays was also acquired from Sigma–Aldrich.
2.2. Sample
Leaves from P. gaudichaudianum were collected in Riozinho (Rio Grande do Sul
province, Brazil) in February, 2010. The voucher specimen was identiﬁed and
deposited at the Herbarium of the Department of Botany, Federal University of
Rio Grande do Sul, Porto Alegre, Brazil (Voucher No.: ICN 128412). The leaves of
P. gaudichaudianum were air-dried and the oil was obtained by hydrodistillation
process for 4 h, using a Clevenger type apparatus, in accordance with the method
recommended by British Pharmacopoeia (2011), producing 0.55% (w/v) of essential
oil. The distilled oil was dried over anhydrous sodium sulfate and stored in closed
dark vials at 4 C until use. The oil was yellow and had a distinct sharp odor. The
essential oil and the standard nerolidol were diluted (1:100 v/v) in hexane prior
to GC  GC/TOF-MS.
2.3. Analysis by GC  GC/TOF-MS
The GC  GC/TOF-MS analyses were performed using an Agilent 6890GC system
with an Pegasus III TOFMS analyzer (LECO Corporation, St. Joseph, MI, USA). The pri-
mary GC column was DB-5 (methyl silicon wit 5% of phenyl substituted groups)eotide excision repair; HR: homologous recombination; NHEJ: non-homologous end-
DNA repair pathway affected Source
– Euroscarfa
BER Euroscarf
NER Euroscarf
NER Euroscarf
PRR Euroscarf
TLS Euroscarf
NHEJ Euroscarf
HR Euroscarf
TLS Euroscarf
TLS Euroscarf
NHEJ Euroscarf
DBgl; leu2-R – RL Swansonb
BER RL Swanson
BER RL Swanson
BER RL Swanson
BER RL Swanson
rad1::hisG BER/NER RL Swanson
rev3::kanMX4 BER/TLS RL Swanson
rad52::URA3 BER/HR RL Swanson
– E Grallac
– E Gralla
– E Gralla
– E Gralla
– E Gralla
– E Gralla
8; hom3-10 – RC Von Borsteld
– JAP Henriquese
Table 2
Fifty six main volatile components identiﬁed in the essential oil of Piper gaudichaudianum leaves using GC  GC-TOFMS.
Peak TR 1st D* (min) TR 2nd D** (min) Compound name Library formula Library CAS– Library molecular weight Library similarity Library reverse match factor Percent response
1 6.70 2.35 Limonene C10H16 138-86-3 136 883 886 0.05
2 7.63 2.72 Linalool C10H18O 22564-99-4 154 874 876 0.04
3 9.63 3.72 Terpineol C10H18O 10482-56-1 154 857 882 0.01
4 15.90 0.04 a-Copaene C15H24 3856-25-5 204 908 910 0.01
5 16.50 0.21 b-Elemene C15H24 515-13-9 204 916 939 0.71
6 17.30 0.37 a-Gurjunene C15H24 489-40-7 204 887 890 0.14
7 17.63 0.23 a-Santalene C15H24 512-61-8 204 882 883 0.33
8 17.63 0.58 Aristolene C15H24 27862-07-3 204 841 850 0.02
9 17.77 0.66 E-caryophyllene C15H24 87-44-5 204 966 966 7.51
10 18.10 0.60 b-Copaene C15H24 18252-44-3 204 894 897 0.20
11 18.23 0.54 c-Elemene C15H24 339154-91-5 204 862 862 0.06
12 18.30 0.25 Trans-a-bergamotene C15H24 26560-14-5 204 893 901 0.23
13 18.57 0.69 Aromadendrene C15H24 489-39-4 204 927 927 2.92
14 19.03 0.90 Trans-muurola-3,5-diene C15H24 189165-77-3 204 787 820 0.06
15 19.30 1.02 a-Humulene C15H24 6753-98-6 204 923 924 21.32
16 19.43 0.64 b-Santalene C15H24 511-59-1 204 903 903 1.08
17 19.57 0.98 Alloaromadendrene C15H24 25246-27-9 204 928 933 3.28
18 19.90 0.98 Drima-7,9(11)-diene C15H24 0-00-0 204 899 899 0.34
19 20.10 0.94 c-Gurjunene C15H24 22567-17-5 204 821 821 0.23
20 20.17 0.96 c-Muurolene C15H24 30021-74-0 204 861 863 0.85
21 20.23 0.67 c-Curcumene C15H24 28976-68-3 204 799 800 0.12
22 20.37 2.35 Germacrene D C15H24 23986-74-5 204 827 914 0.03
23 20.70 1.22 b-Selinene C15H24 17066-67-0 204 919 919 3.43
24 21.10 1.20 a-Selinene C15H24 473-13-2 204 925 927 2.67
25 21.17 1.38 Bicyclogermacrene C15H24 24703-35-3 204 923 923 13.16
26 21.23 1.13 a-Muurolene C15H24 31983-22-9 204 853 855 0.73
27 21.50 0.68 E,E-a-farnesene C15H24 502-61-4 204 928 930 1.31
28 21.57 1.21 d-Amorphene C15H24 189165-79-5 204 854 854 0.21
29 21.57 1.40 Germacreno A C15H24 28387-44-2 204 835 837 0.12
30 21.70 0.95 b-Curcumene C15H24 28976-67-2 204 818 820 0.52
31 21.90 1.37 c-Cadinene C15H24 39029-41-9 204 893 893 1.27
32 22.10 1.52 7-Epi-a-Selinene C15H24 123123-37-5 204 812 812 0.16
33 22.30 1.32 d-Cadinene C15H24 483-76-1 204 901 903 1.47
34 22.43 1.49 Zonarene C15H24 95910-36-4 204 820 888 0.01
35 22.70 1.07 c-E-bisabolene C15H24 53585-13-0 204 851 851 0.21
36 22.97 1.45 a-Cadinene C15H24 82468-90-4 204 846 846 0.15
37 23.23 2.44 a-Colacorene C15H20 21391-99-1 200 884 884 0.16
38 23.57 1.84 Elemol C15H26O 639-99-6 222 839 840 0.27
39 23.97 1.93 Germacreno B C15H24 15423-57-1 204 882 886 0.37
40 24.03 1.30 E-nerolidol C15H26O 142-50-7 222 931 919 22.06
41 24.50 1.87 Ledol C15H26O 577-27-5 222 824 850 0.04
42 25.03 2.55 Spathulenol C15H24O 77171-55-2 220 867 879 1.97
43 25.23 2.69 Caryophyllene oxide C15H24O 1139-30-6 220 861 865 0.01
44 25.30 2.65 Globulol C15H26O 51371-47-2 222 810 810 0.16
45 26.23 2.36 Viridiﬂorol C15H26O 552-02-3 222 822 833 0.18
46 26.50 2.97 Humulene epoxide II C15H24O 19888-34-7 220 835 836 2.27
47 26.77 2.30 1,10-Di-epi-cubenol C15H26O 73365-77-2 222 824 824 0.09
48 27.63 2.91 Epoxy-allo alloaromadendrene C15H24O 85760-81-2 220 758 818 0.00
49 27.77 3.04 Caryophylla-4(14),8(15)-dien-5-a-ol C15H24O 147235-15-2 220 867 870 0.15
50 28.03 3.22 a-Muurolol C15H26O 19912-62-0 222 732 903 0.02
51 28.63 2.87 a-Cadinol C15H26O 481-34-5 222 816 818 0.26
52 28.70 3.19 Intermedeol C15H26O 5945-72-2 222 862 862 0.45
53 29.37 2.23 a-Bisabolol C15H26O 15352-77-9 222 827 827 0.18
54 29.90 3.30 Z-a-Trans-bergamotol C15H24O 88034-74-6 220 764 770 0.09
55 30.17 2.34 a-Bisabolol C15H26O 515-69-5 222 734 874 0.02
56 30.43 3.30 Z,E-farnesol C15H26O 3790-71-4 222 785 786 0.12
93.86
* TR 1st D – Retention times on the ﬁrst dimension.
** TR 2st D – Retention times on the second dimension.
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60 A.R.M. Sperotto et al. / Food and Chemical Toxicology 57 (2013) 57–68(60 m  0.25 mm  0.1 lm) and secondary column used was DB-17MS (methyl sil-
icon wit 50% of phenyl substituted groups) (2.15 m  0.18 mm  0.18 lm), both
from J&W-Agilent (Folsom, CA, USA). The primary oven temperature program was
105 C (0.2 min)–2 C/min–200 C, the secondary oven with 10 C offset. Modula-
tion time was 4 s, with a 1.6 s hot pulse and 0.4 s cold pulse in each stage. The car-
rier gas used was Helium (from White Martins, 99.999% purity) with constant ﬂow
rate of 1.0 mL/min, injector with split rate of 1:50, temperature for the injector, the
transfer line and the ion source were set at 250 C, 250 C and 250 C, respectively.
The acquisition rate 100 s/s and mass range of m/z 50-450. The components were
quantiﬁed by LECO Corp ChromaTOFTM version 3.1. All peaks with signal-to-noise
ratio higher than 100 were found in the raw GC  GC chromatogram. The worksta-
tion automatically gave the parameters such as similarity and reverse of peaks
through comparing them with the compounds in the library. The results were com-
bined in a peak table. The NIST/EPA/NIH Mass Spectral Library Version 2.0 was used
in this work.
2.4. Yeast strains and media
The relevant genotypes of the S. cerevisiae strains used in this work are indi-
cated in Table 1. Yeast media used were the complete liquid medium (YPD), mini-
mal medium (MM) and synthetic complete medium (SC) described in Burke et al.
(2000). For mutagenesis of the XV185-14c strain, the omission media, lacking lysine
(SC-lys), histidine (C-his) or homoserine (SC-hom), was supplemented with 0.1 mg
lysine, histidine, or methionine, respectively, per 100 mL of MM (Von Borstel et al.,
1971). For the determination of forward mutagenesis in strain N123, plates lacking
arginine were supplemented with 60 lg/mL canavanine (SC + can).
2.5. Yeast growth conditions and treatment
Stationary- and exponential phase cultures were used, and the cell concentra-
tion and budding percentage was performed by microscopic counts using a Neu-
bauer chamber. The XV185-14c yeast strain was used to determine the
concentrations of the P. gaudichaudianum essential oil and nerolidol to be tested
in this study, based on the recommendations of the OECD Guidelines for the Testing
of Chemicals (Genetic Toxicology: Saccharomyces cerevisiae, Gene Mutation Assay:
No. 480). For all treatments, DMSO stock solutions of P. gaudichaudianum and ner-
olidol were prepared immediately prior to use so that the DMSO concentration in
the treatment never exceeded 0.2%. The appropriate concentrations were obtained
by dilution of stock solutions in distilled water. The solvent controls included in the
tests were found to be negative. The 4-NQO (0.5 lg/mL) and H2O2 (4 mM) were
used as positive control in the mutagenic and DCF-DA assays, respectively.
2.6. Detection of reverse and frameshift mutations in the XV185-14c haploid strain
Suspensions of 2  108 cells/mL in stationary or exponential growth phases
were incubated in phosphate-buffered saline solution (PBS; Na2HPO4, KH2PO4 and
KCl; 20 mM; pH 7.4) for mutagenic evaluation under non-growth conditions, or
in fresh synthetic media for mutagenic evaluation under growth conditions, with
different concentrations of P. gaudichaudianum essential oil or nerolidol (0.5, 1,
10, 25, 50 and 100 lg/mL) at 30 C for 18 h. Survival was determined on SC (3–
5 days, 30 C) and mutation induction (LYS, HIS or HOM revertants) on the
appropriate omission media (7–10 days, 30 C). While his1-7 is a non-suppressible
missense allele and reversions result frommutation at the locus itself (Snow, 1978),
lys1-1 is a suppressible ochre nonsense mutant allele (Hawthorne, 1969) that can be
reverted either by a locus-speciﬁc mutation or by a forward mutation in a
suppressor gene (Von Borstel et al., 1971). The two mutation types at the lys1-1
locus were differentiated according to Schuller and von Borstel (1974). It is believed
that hom3-10 contains a frameshift mutation due to its response to a range of
diagnostic mutagens (Von Borstel et al., 1971).
2.7. Detection of forward mutations in the N123 strain
Yeast cells in stationary or exponential growth phase (2  108 cells/mL) were
treated for 18 h at 30 C with P. gaudichaudianum essential oil or nerolidol at in-
creased concentrations varying from 0.5 to 100 lg/mL. After treatment, appropriate
dilutions of cells were plated onto SC plates to determine cell survival and were
then plated onto SC media supplemented with canavanine (60 lg/mL) in order to
determine the presence of a forward mutation in the CAN1 locus. Plates were incu-
bated in the dark at 30 C for 3–5 days before assaying survival and counting the
revertant colonies.
2.8. Survival assays
The relative sensitivity of the DNA repair pathway-defective strains was as-
sayed by treating 1  108 cells/mL exponential cultures in PBS with various concen-
trations of P. gaudichaudianum essential oil or nerolidol (0.5, 1, 10, 25, 50 and
100 lg/mL), followed by incubation with aeration by rotary shaking at 30 C for
18 h. The strains deﬁcient in superoxide dismutase and/or catalase were treated
with P. gaudichaudianum essential oil or nerolidol in PBS at 30 C for 1 h withagitation. To determine colony-forming ability, suitable aliquots were plated on
YPD. Plates were incubated at 30 C for 2–4 days before the surviving colonies were
counted.2.9. Determination of reactive oxygen species (ROS) generation
The DCFH-DA assay was used to estimate the intracellular generation of ROS.
This assay is a reliable method for measuring intracellular ROS such as H2O2, hydro-
xyl radical (OH), and hydroperoxides (ROOH). The dye is a non-polar compound
that readily penetrates into cells. Intracellular peroxides oxidize DCFH-DA to a
highly ﬂuorescent compound (20 ,70-dichloroﬂuorescein; DCF). After treatment with
P. gaudichaudianum essential oil or nerolidol for 1 h at 30 C, SOD-WT, sod1D and
sod2D yeast cells were washed and incubated with 10 lM DCFH-DA for 30 min at
37 C in the dark. The H2O2 (4 mM) was used as positive control. After incubation,
the cells were washed with PBS and analyzed within 30 min using FACS Calibur
(Becton Dickinson, San Jose, CA, United States). The DCFH-oxidation was measured
using 488 nm excitation and 530/30 nm band pass emission ﬁlters. As a rule, 10,000
cells were counted in each experiment. The Cell Quest software (Becton Dickinson)
was used to calculate the mean ﬂuorescence. Data were expressed as percentages of
control values.2.10. Statistics
All experiments were independently repeated at least three times, with tripli-
cate samples for each treatment. Data were expressed as means ± standard devia-
tion (S.D.) values. Statistical analyses of the data were performed using ANOVA
One-Way, and the means were compared using Dunnett’s multiple comparison test.
P-values less than 0.05 were considered to be signiﬁcant.3. Results
3.1. Analysis of P. gaudichaudianum essential oil and nerolidol by
GC  GC/TOF-MS
In the GC  GC system, compounds are separated by volatility
difference on the ﬁrst dimension non-polar column, and by polar-
ity on the second medium-polar column. The composition of the
volatile fraction obtained from P. gaudichaudianum essential oil
leaves using the GC  GC/TOF-MS technique is summarized in Ta-
ble 2. Identiﬁcation based on NIST/EPA/NIH library mass spectra
search using similarity and reverse factors was above 731 and
769, respectively. This technique is based on the application of
two GC columns coated with different stationary phases connected
in series through a special interface called modulator. The modula-
tor is the heart of the instrument because it ensures that the sep-
aration is both comprehensive and multidimensional (Welke
et al., 2012). The addition of the TOFMS provides a sensitive detec-
tor with full-scan MS capability and a high data density in the 2D
separation space. The combination of GC  GC/TOF-MS has been
shown to be very useful for many complex samples (Von Muhlen
et al., 2008). Fifty six volatile compounds from the essential oil of
P. gaudichaudianum leaves were identiﬁed. The essential oil is char-
acterized by high percentages of sesquiterpenes. In this study, the
percentages of (E)-nerolidol and a-humulene found in the essential
oil were 22.06% and 21.32%, respectively.
A typical two-dimensional separation/total ion chromatogram
(TIC) of the essential oil is shown in Fig. 1 and the nerolidol chro-
matogram (a mixture of cis- and trans-nerolidol from Sigma–Al-
drich) is shown in Fig. 2A. The chromatographic peak data
consist of ﬁrst dimension retention times, second dimension reten-
tion times and peak volume (TIC). The GC  GC chromatogram is
constructed as a rasterized image of the TIC computed from each
secondary chromatogram. Fig. 2B compares the mass spectrum of
the blod (peak) at 24.03 min in the sample of essential oil, the sam-
ple of standard and the mass spectrum of (E)-nerolidol from the
NIST/EPA/NIH library mass spectra and conﬁrmed that in P. gaudi-
chaudianum essential oil has only trans-nerolidol, according to
retention time.
Fig. 1. GC  GC-TOFMS total ion current chromatogram (TIC) data color plot of P. gaudichaudianum essential oil. Detail of a 2D-GC chromatogram from 6.5 to 45 min.
Fig. 2. Expansion of a part of the GC  GC contour plot of standard nerolidol (a racemic mixture of cis and trans isomers). (A) Detail of a 2D-GC chromatogram from 23.5 to
25 min. (B) Spectra of a majority peak in the sample, spectra of an identiﬁcation peak in the standard and in the NIST library, respectively. The experimental conditions are
given in the text.
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As shown in Table 3, P. gaudichaudianum essential oil induced
dose-dependent cytotoxic effects both in stationary and exponentialphase cultures in the XV185-14c strain, with a signiﬁcant effect at
the concentrations of 50 and 100 lg/mL. The essential oil induced a
signiﬁcant increase in mutation frequencies only at the lys1 locus
at the highest concentration and in cultures treated at the
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14c at concentration of 25, 50 and 100 lg/mL and did not demon-
strate any induction of mutagenicity at the three loci evaluated
(Table 4). To complement this study, we used the N123 strain to
evaluate the cytotoxicity as well as the induction of forward
mutations. In this strain, we did not observe any mutagenic effect
for either the essential oil (Table 5) or nerolidol (Table 6), but the
cytotoxic effects were pronounced after nerolidol treatment. The
treatments under growth conditions were always more cytotoxic
for both samples, independent of the tested strain. At the highest
concentration (100 lg/mL) used, nerolidol induced cytotoxicity
that was at least ﬁve times higher than that induced by the essen-
tial oil of P. gaudichaudianum, regardless of the strain tested.
3.3. Cytotoxicity effects in S. cerevisiae DNA repair-defective strains
Due to the high toxicity observed, we decided to evaluate the
interaction of DNA repair pathways in response to the P. gaudi-
chaudianum essential oil and nerolidol-induced DNA damage.
Therefore, we performed survival assays to compare the sensitivi-
ties of single, double, triple and quadruple mutants defective in
BER, NER, HR, NHEJ, PRR and TLS. Among the BER-deﬁcient strains,
P. gaudichaudianum essential oil displayed increased cytotoxicity in
the single mutant ntg2D and the double mutant ntg1Dntg2D when
compared to the isogenic wild-type SJR751 strain (Fig. 3A). Nerol-
idol induced cytotoxicity to ntg1D, ntg1Dntg2D, and
ntg1Dntg2Dapn1D mutants increased compared to the isogenic
SJR751 (Fig. 3B), as did the cytotoxicity in the single mutant apn1D
in relation to the isogenic wild-type BY4741 strain (Fig. 3B and
Fig. 3C). The Ntg1 and Ntg2 proteins are DNA N-glycosylase and
apurinic/apyrimidinic (AP) lyase, respectively, and the Apn1 pro-
tein is a major apurinic/apyrimidinic endonuclease with 30-repairTable 3
Reversion of point mutation for (his1-7), ochre allele (lys1-1), and frameshift mutations (ho
oil treatment at 30 C for 18 h.
Agent Treatment Survival (%) LYS1/
Treatment of stationary-phase cells under non-growth conditions
NCc 0 100.00 (231) 1.66
4-NQOd 0.5 lg/mL 59.46 ± 3.46 (137) 22.84
Essential oil 1 lg/mL 96.81 ± 2.37 (221) 1.83
10 lg/mL 89.30 ± 2.10 (209) 1.82
25 lg/mL 73. 07 ± 0.53 (169) 2.57
50 lg/mL 62.20 ± 1.67 (143) 3.44
100 lg/mL 46.12 ± 5.83 (106) 4.89
Treatment of exponential-phase cells under non-growth conditions
NCc 0 100. 00 (191) 1.64
4-NQOd 0.5 lg/mL 49.59 ± 2.60 (93) 19.04
Essential oil 1 lg/mL 89.96 ± 1.43 (173) 2.17
10 lg/mL 78.60 ± 1.89 (149) 2.69
25 lg/mL 73.19 ± 0.98 (141) 3.05
50 lg/mL 56. 91 ± 3.62 (105) 4.27
100 lg/mL 22. 15 ± 2.53 (43) 6.97
Treatment under growth conditions
NCc 0 100.00 (409) 1.76
4-NQOd 0.5 lg/mL 36.88 ± 2.57 (149) 39.9
Essential oil 1 lg/mL 83.41 ± 2.17 (342) 3.02
10 lg/mL 75.67 ± 3.28 (306) 4.02
25 lg/mL 64.61 ± 0.34 (264) 5.33
50 lg/mL 42.15 ± 2.59 (170) 9.63
100 lg/mL 12.20 ± 2.97 (48) 22.34
Data represented as mean ± S.D. from three independent experiments (values in parenth
to the negative control group at P < 0.05; P < 0.01; P < 0.001 by one-way ANOVA Du
a Locus-speciﬁc revertants.
b Locus non-speciﬁc revertants (forward mutation).
c Negative control (solvent; DMSO).
d Positive control: 4-NQO treatment at 0.5 lg/ml.diesterase action (Boiteux and Guillet, 2004; Doetsch et al.,
2001). The rad1D and rad10D strains, which lack the 50- and 30-
endonucleases of NER (Prakash and Prakash, 2000), showed an
intermediate sensitivity to P. gaudichaudianum essential oil
(Fig. 4A). These single mutants had the same nerolidol sensitivity
as the wild-type BY4741 strain (Fig. 4B).
Among the double-strand repair defective strains, the essential
oil induced a moderate sensitivity in the rad50D mutant (Rad50
protein is a subunit of the MRX complex involved in both HR and
NHEJ) and did not induce sensitivity in rad52D (HR) or ku70D
(NHEJ) mutants (Fig. 5A). The rad50D, rad52D and ku70D mutants
as well as the isogenic BY4741 strain showed dose-dependent sen-
sitivity to Nerolidol (Fig. 5B and C).
Deletion of the TLS and PRR proteins had no inﬂuence on the
sensitivity to P. gaudichaudianum essential oil (Fig. 6A). Interest-
ingly, nerolidol exhibited a remarkable resistance in several of
these mutants, as observed in Fig. 6B: rev1D, which is deﬁcient
in the deoxycytidyl transferase that forms a complex with DNA
polymerase f in TLS (Lawrence, 2004); rad30D, which lacks poly-
merase eta, which is involved in TLS during post-replication repair,
catalyzing the synthesis of DNA opposite cyclobutane pyrimidine
dimers and other lesions (Ai et al., 2011); and rad18D, which is
deﬁcient in the E3 ubiquitin ligase that forms a heterodimer with
Rad6p to monoubiquitinate PCNA in PRR (Prakash et al., 2005).
The absence of Rev3, the catalytic subunit of polymerase f (Law-
rence, 2004), also had a small effect on the sensitivity to nerolidol
(Fig. 6B and Fig. 6C).
To evaluate the overlap of different DNA repair pathways, the
mutants without DNA repair proteins from BER, NER, HR or TLS
were used. P. gaudichaudianum essential oil induced slight cyto-
toxic effects in the quadruple mutants ntg1Dntg2Dapn1Drad1D
and ntg1Dntg2Dapn1Drad52D, while the nerolidol induced slightm3-10) in haploid XV185-14c strain of S. cerevisiae after P. gaudichaudianum essential
107 survivorsb HIS1/107 survivorsa HOM3/107 survivorsa
± 0.44 (37) 1.65 ± 0.167 (43) 0.94 ± 0.25 (21)
± 0.34 (311) 35.12 ± 3.23 (426) 21.56 ± 3.59 (287)
± 0.76 (40) 2.13 ± 0.55 (43) 1.06 ± 0.34 (22)
± 0.43 (37) 2.42 ± 0.31 (45) 1.32 ± 0.47 (26)
± 0.72 (42) 2.61 ± 0.34 (45) 1.66 ± 0.34 (28)
± 1.02 (47) 2.99 ± 1.04 (45) 1.93 ± 0.19 (27)
± 0.93 (53) 3.85 ± 1.41 (38) 2.21 ± 0.20 (24)
± 0.15 (32) 1.46 ± 0.26 (25) 1.42 ± 0.53 (21)
± 5.76 (207) 29.82 ± 3.31 (277) 25.13 ± 5.15 (24)
± 0.64 (35) 1.93 ± 0.34 (29) 1.77 ± 0.59 (23)
± 0.166 (39) 2.40 ± 0.38 (32) 1.56 ± 0.16 (27)
± 0.33 (40) 2.15 ± 0.65 (30) 2.08 ± 0.35 (27)
± 0.83 (40) 3.02 ± 0.76 (27) 2.17 ± 0.75 (24)
± 0.27 (31) 4.75 ± 1.16 (19) 5.29 ± 0.69 (25)
± 0.45 (70) 1.49 ± 0.32 (59) 1.21 ± 0.29 (47)
± 2.56 (454) 25.32 ± 3.91 (386) 27.86 ± 2.88 (245)
± 1.10 (95) 1.74 ± 0.58 (65) 1.5 ± 0.68 (49)
± 1.00 (117) 1.98 ± 0.94 (68) 1.68 ± 0.41 (51)
± 1.65 (134) 2.43 ± 0.90 (71) 1.67 ± 0.44 (46)
± 1.68 (161) 2.83 ± 1.00 (52) 2.25 ± 1.14 (42)
± 2.97 (105) 5.42 ± 0.50 (26) 3.79 ± 0.78 (19)
eses in columns 3–6 refers to number of colonies); signiﬁcantly different in relation
nnett’s Multiple Comparison Test.
Table 4
Reversion of point mutation for (his1-7), ochre allele (lys1-1), and frameshift mutations (hom3-10) in haploid XV185-14c strain of S. cerevisiae after nerolidol treatment at 30 C for
18 h.
Agent Treatment Survival (%) LYS1/107 survivorsb HIS1/107 survivorsa HOM3/107 survivorsa
Treatment of stationary-phase cells under non-growth conditions
NCc 0 100.00 (269) 1.40 ± 0.59 (31) 2.35 ± 1.14 (55) 1.87 ± 1.00 (34)
4-NQOd 0.5 lg/mL 56.56 ± 2.36(153) 16.87 ± 2.22 (247) 20.30 ± 2.05 (305) 14.18 ± 2.00 (209)
Nerolidol 1 lg/mL 91.98 ± 2.09(246) 1.76 ± 0.74 (31) 2.87 ± 1.12(63) 14.18 ± 2.00 (33)
10 lg/mL 79.26 ± 4.88 (210) 2.42 ± 0.84 (40) 3.92 ± 1.46 (75) 2.15 ± 0.91 (33)
25 lg/mL 70.19 ± 4.33 (189) 2.16 ± 0.53 (37) 4.34 ± 1.16 (79) 1.97 ± 0.47 (23
50 lg/mL 43.90 ± 4.52(121) 1.16 ± 0.99 (14) 4.33 ± 0.91 (66) 1.77 ± 0.03 (12)
100 lg/mL 8.98 ± 2.38 (106) 0.24 ± 0.22 (5) 5.41 ± 0.99 (32) 0.42 ± 0.20 (2)
Treatment of exponential-phase cells under non-growth conditions
NCc 0 100. 00 (194) 1.63 ± 0.28 (32) 1.49 ± 0.29 (29) 1.33 ± 0.08 (26)
4-NQOd 0.5 lg/mL 54.40 ± 4.18 (106) 16.06 ± 4.29 (164) 20.04 ± 5.81(203) 13.68 ± 2.12 (145)
Nerolidol 1 lg/mL 86.59 ± 2.26 (169) 2.33 ± 0.14 (39) 2.23 ± 0.58 (37) 1.60 ± 0.30 (27)
10 lg/mL 80.67 ± 2.13 (157) 2.59 ± 0.11 (41) 2.53 ± 0.76 (39) 1.17 ± 0.15 (18)
25 lg/mL 64.71 ± 2.10 (126) 2.66 ± 0.16 (34) 3.24 ± 0.57 (40) 0.94 ± 0.16 (11)
50 lg/mL 35.33 ± 4.01 (69) 3.59 ± 1.08 (24) 4.85 ± 1.03 (32) 0.96 ± 0.42 (6)
100 lg/mL 5.22 ± 1.35 (11) 4.23 ± 2.20 (5) 5.09 ± 0.95 (6) 0.64 ± 1.11 (1)
Treatment under growth conditions
NCc 0 100.00 (309) 1.00 ± 0.33 (45) 1.62 ± 0.79 (59) 1.0 ± 0.42 (28)
4-NQOd 0.5 lg/mL 38.63 ± 2.38 (120) 17.76 ± 6.20 (239) 20.11 ± 1.71 (386) 14.72 ± 3.06 (170)
Nerolidol 1 lg/mL 87.07 ± 0.923 (270) 1.59 ± 0.42 (49) 2.01 ± 0.87 (65) 1.14 ± 0.50 (28)
10 lg/mL 76.56 ± 1.54 (237) 1.78 ± 0.39 (51) 2.27 ± 0.59 (68) 1.46 ± 0.40 (33)
25 lg/mL 58.30 ± 3.62 (180) 2.07 ± 0.47 (46) 2.77 ± 1.01 (71) 1.85 ± 0.57 (20)
50 lg/mL 34.01 ± 5.22 (102) 1.62 ± 0.74 (38) 3.68 ± 0.66 (52) 2.26 ± 1.17 (22)
100 lg/mL 2.51 ± 1.99 (7) 1.11 ± 1.92 (3) 4.86 ± 1.59 (26) 4.05 ± 0.63 (3)
Data represented as mean ± S.D. from three independent experiments (values in parentheses in columns 3–6 refers to number of colonies); signiﬁcantly different in relation
to the negative control group at P < 0.05; P < 0.01; P < 0.001 by one-way ANOVA Dunnett’s Multiple Comparison Test.
a Locus-speciﬁc revertants.
b Locus non-speciﬁc revertants (forward mutation).
c Negative control (solvent; DMSO).
d Positive control: 4-NQO treatment at 0.5 lg/ml.
Table 5
Induction of forward mutation (CAN1) in N123 strain of S. cerevisiae after P.
gaudichaudianum essential oil treatment at 30 C for 18 h.
Agent Treatment Survival (%) Mutants (107 survivors)
Treatment of stationary-phase cells under non-growth conditions
NCa 0 100.00 ± (57) 5.22 ± 2.68 (30)
4-NQOb 0.5 lg/mL 39.91 ± 1.69 (26) 78.50 ± 5.72 (169)
Essential oil 1 lg/mL 98.35 ± 0.59 (56) 5.41 ± 3.36 (32)
10 lg/mL 94.98 ± 3.57 (54) 5.59 ± 3.27 (28)
25 lg/mL 91.78 ± 1.81 (52) 6.33 ± 3.87 (33)
50 lg/mL 80.46 ± 5.33 (47) 7.17 ± 4.58 (32)
100 lg/mL 68.52 ± 3.30 (39) 8.79 ± 6.10 (34)
Treatment of exponential-phase cells under non-growth conditions
NCa 0 100.00 (37) 5.32 ± 1.93 (21)
4-NQOb 0.5 lg/mL 30.08 ± 5.30 (12) 81.79 ± 4.70 (94)
Essential oil 1 lg/mL 95.91 ± 2.65 (36) 5.59 ± 2.04 (21)
10 lg/mL 89.36 ± 3.33 (35) 5.94 ± 1.63 (20)
25 lg/mL 84.70 ± 1.19 (32) 6.346 ± 2.36 (21)
50 lg/mL 79.74 ± 2.96 (30) 6.49 ± 0. 219 (20)
100 lg/mL 59.53 ± 3.65 (23) 6.29 ± 3.14 (15)
Treatment under growth conditions
NCa 0 100.00 (45) 4.32 ± 1.84 (19)
4-NQOb 0.5 lg/mL 28.00 2.37 (13) 96.95 ± 1.10 (121)
Essential oil 1 lg/mL 96.32 ± 2.97 (43) 4.63 ± 2.19 (20)
10 lg/mL 93.86 ± 2.91 (42) 5.72 ± 2.70 (24)
25 lg/mL 88.27 ± 3.38 (39) 5.51 ± 3.05 (21)
50 lg/mL 69.36 ± 2.74 (31) 6.72 ± 2.43 (21)
100 lg/mL 48.10 ± 1.27 (22) 8.55 ± 2.09 (19)
Data represented as mean ± S.D. from three independent experiments (values in
parentheses in columns 3 and 4 refers to number of colonies); signiﬁcantly different
in relation to the negative control group at P < 0.05; P < 0.01/ P < 0.001 by one-
way ANOVA Dunnett’s Multiple Comparison Test.
a Negative control (solvent; DMSO).
b Positive control: 4-NQO treatment at 0.5 lg/ml.
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fects on the ntg1Dntg2Dapn1Drev3D strain (Fig. 7).3.4. Cytotoxicity in strains deﬁcient in superoxide dismutase and/or
catalase
To analyze the possible involvement of the essential oil and ner-
olidol in the generation of ROS, we used the strains deﬁcient in
superoxide dismutase and/or catalase. The essential oil exhibited
a small amount of cytotoxicity in the sod1D single mutant (lacks
cytoplasmic superoxide dismutase) (Fig. 8A), and nerolidol exhib-
ited little cytotoxicity in the sod1D and sod2D single mutants
(lacks mitochondrial superoxide dismutase) as well as the double
mutant sod1Dsod2D (Fig. 8B).3.5. Effects of P. gaudichaudianum essential oil and nerolidol on ROS
generation
The results of the DCF assay indicated that P. gaudichaudianum
essential oil and nerolidol caused an increase in the intracellular
levels of ROS. The relative DCF ﬂuorescence intensities measured
after treatment showed that at 100 lg/mL, P. gaudichaudianum
essential oil induces an ROS increase in SOD-WT and sod1D strains
(Table 7). The nerolidol was also able to signiﬁcantly increase the
ROS level in all tested strains (SOD-WT, sod1D and sod2D at the
highest concentration Table 7).4. Discussion
(E)-Nerolidol is one of the major sesquiterpenes present in the
essential oil of P. gaudichaudianum that was identiﬁed in a sample
collected in 2006 by our research group. When GC-MS was used,
47 compounds were tentatively identiﬁed, and the major com-
pounds were (E)-nerolidol (22.4%), a-humulene (16.5%), (E)-caryo-
phyllene (8.9%) and bicyclogermacrene (7.4%) (Péres et al.,
2009).While, we identiﬁed 56 volatile compounds (Table 2) with
Table 6
Induction of forward mutation (CAN1) in N123 strain of S. cerevisiae after nerolidol
treatment at 30 C for 18 h.
Agent Treatment Survival (%) Mutants (107
survivors)
Treatment of stationary-phase cells under non-growth conditions
NCa 0 100.00 (91) 2.22 ± 0.70 (27)
4-NQOb 0.5 lg/mL 33.48 ± 3.02 (31) 64.74 ± 3.20 (198)
Nerolidol 1 lg/mL 89.16 ± 2.29 (82) 2.46 ± 0.93 (25)
10 lg/mL 77.12 ± 3.30 (71) 3.18 ± 1.04 (24)
25 lg/mL 64.34 ± 2.92 (58) 3.22 ± 1.28 (22)
50 lg/mL 39.94 ± 3.39 (38) 3.63 ± 1.37 (13)
100 lg/
mL
11.41 ± 3.64 (12) 3.62 ± 1.79 (4)
Treatment of exponential-phase cells under non-growth conditions
NCa 0 100.00 (64) 3.00 ± 0.58 (19)
4-NQOb 0.5 lg/mL 26.83 ± 2.71 (18) 60.33 ± 1.59 (105)
Nerolidol 1 lg/mL 87.77 ± 1.63 (57) 2.89 ± 0.64 (17)
10 lg/mL 75.39 ± 2.75 (49) 3.35 ± 1.03 (16)
25 lg/mL 57.49 ± 0.17 (37) 4.07 ± 0.88 (14)
50 lg/mL 38.09 ± 2.52 (25) 5.13 ± 0.83 (13)
100 lg/
mL
7.03 ± 0.89 (5) 4.84 ± 0.26 (2)
Treatment under growth conditions
NCa 0 100.00 (107) 2.90 ± 0.48 (30)
4-NQOb 0.5 lg/mL 20.49 ± 1.45 (22) 80.55 ± 4.95 (175)
Nerolidol 1 lg/mL 86.08 ± 2.25 (92) 3.29 ± 0.65 (29)
10 lg/mL 73.14 ± 4.17 (79) 3.80 ± 0.68 (29)
25 lg/mL 64.21 ± 4.12 (69) 3.75 ± 1.12 (24)
50 lg/mL 34.41 ± 3.74 37) 3.90 ± 0.78 (13)
100 lg/
mL
6.62 ± 1.39 (8) 4.84 ± 1.24 (3)
Data represented as mean ± S.D. from three independent experiments (values in
parentheses in columns 3 and 4 refers to number of colonies); signiﬁcantly different
in relation to the negative control group at P < 0.05; P < 0.01/ P < 0.001 by one-
way ANOVA Dunnett’s Multiple Comparison Test.
a Negative control (solvent; DMSO).
b Positive control: 4-NQO treatment at 0.5 lg/ml.
Fig. 3. Survival of S. cerevisiae strains deﬁcient in BER after treatment with P. gaudichaudianum essential oil (A) and nerolidol (B). In detail, the BY4741 and apn1D strains after
nerolidol treatment (C). The survival of the parental strain (BY4741 and SJR751) is compared to that of variants defective for the BER proteins Apn1, Ntg1 and Ntg2.
Fig. 4. Survival of S. cerevisiae strains deﬁcient in NER after treatment with P.
gaudichaudianum essential oil (A) and nerolidol (B). The survival of the parental
strain (BY4741) is compared to that of variants defective for the NER endonucleases
Rad1 and Rad10.
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as shown in Table 2. The analysis of GC-MS has some widely
known limitations, such as cases in which coelutions are unavoid-
able and frequent in complex samples, which renders the spectra
unsuitable for qualitative purposes, or for species in very low con-
Fig. 5. Survival of S. cerevisiae strains deﬁcient in HR and NHEJ after treatment with P. gaudichaudianum essential oil (A) and nerolidol (B). In detail, the BY4741, rad50D and
ku70D strains after nerolidol treatment (C). The survival of the parental strain (BY4741) is compared to that of variants defective for the HR protein Rad52 and NHEJ proteins
Rad50 and Ku70.
Fig. 6. Survival of S. cerevisiae strains deﬁcient in TLS after treatment with P. gaudichaudianum essential oil (A) and nerolidol (B). In detail, the BY4741 and rev3D strains after
nerolidol treatment (C). The survival of the parental strain (BY4741) is compared to that of variants defective for the TLS proteins Rev1, Rev3, Rad18 and Rad30.
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achieved even with good quality spectra, notably for compounds
having several highly similar structural isomers, presenting com-
parable fragmentation patterns (Pedroso et al., 2011). Such prob-lems can be avoided by using comprehensive two-dimensional
GC (GC  GC) (Tranchida et al., 2010). Using this method, our re-
sults showed that the (E)-nerolidol is the major compound present
in P. gaudichaudianum essential oil (Fig. 2 B). The differences in
Fig. 7. Survival of S. cerevisiae quadruple mutant strains deﬁcient in BER, HR, NER
and TLS after treatment with P. gaudichaudianum essential oil (A) and nerolidol (B).
The survival of the parental strain (SJR751) is compared to that of variants defective
for the BER proteins Apn1, Ntg1 and Ntg2, the NER protein Rad1, the HR protein
Rad52, the NER endonuclease Rad1 and the TLS protein Rev3.
Fig. 8. Survival of S. cerevisiae single and double mutant strains deﬁcient in
superoxide dismutase and/or catalase after treatment with P. gaudichaudianum
essential oil (A) and nerolidol (B). The survival of the parental strain (SOD) is
compared to that of variants defective for the superoxide dismutase proteins Sod1
and Sod2 and the catalase protein Ctt1.
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sonal and climatic conditions (Péres et al., 2009).
In order to gain further insight into the biological properties of
P. gaudichaudianum essential oil and nerolidol, we evaluated the
response of strains defective in DNA repair as well as themutagenic and oxidative properties of these components using
the yeast S. cerevisiae as a model organism.
P. gaudichaudianum essential oil showed cytotoxic effects in the
XV185-14c and N123 strains but induced mutagenesis only at the
lys1 locus at the highest concentration. The nerolidol cytotoxic ef-
fects were more pronounced compared to those of the essential oil
in these strains, and it did not induce any type of mutagenesis. In
our previous work with V79 cultured mammalian cells, we have
shown, using the alkaline version of the comet assay, that P. gaud-
ichaudianum essential oil induces signiﬁcant single DNA strand
breaks and alkali-labile sites, however it does not induce DNA dou-
ble strand breaks. Also, it presented mutagenic effects as shown by
micronucleus assay. However, these effects appeared to be indi-
rect, occurring as a result of ROS generation, since a lipid peroxida-
tion increase was detected in these cells after treatment with the
essential oil (Péres et al., 2009). The absence of nerolidol (a racemic
mixture of cis and trans isomers) mutagenic effects are in accor-
dance with Gonçalves et al. (2011), who demonstrated that nerol-
idol does not have a mutagenic effect using the Salmonella
typhimurium TA100 and TA98 strains in the presence or absence
of metabolic activation systems, although nerolidol did induce
cytotoxicity in these strains. Additionally, in mouse cells, nerolidol
induces clastogenicity but very weak genotoxicity (Pículo et al.,
2011).
To determine whether the essential oil and nerolidol exert di-
rect or indirect effects on DNA, we evaluated the sensitivity of
DNA repair defective S. cerevisiae strains to these compounds.
Our results indicate that the ntg2D single mutant and ntg1Dntg2D
double mutant display sensitivity after the P. gaudichaudianum
essential oil treatment, the ntg1D and apn1D single mutants, the
ntg1Dntg2D double mutant and the ntg1Dntg2Dapn1D triple mu-
tant showed increased sensitivity to nerolidol Fig. 3); the proteins
that are absent in these strains belong to the BER pathway. The BER
primarily involves the repair of oxidative DNA damage, which
encompasses the small helix non-distorting base lesion and abasic
sites (Lindahl and Wood, 1999; You et al., 1999). Our data indicate
that BER enzymes involved in the repair of lesions are induced,
most likely indirectly, by P. gaudichaudianum essential oil and
nerolidol.
There is an overlap between BER and NER with respect to DNA
damage processing, such as during the repair of thymine glycol and
8-oxoguanine oxidative lesions (Boiteux and Guillet, 2004). Our re-
sults indicate that the NER-deﬁcient strains rad1D and rad10D
have an intermediary sensitivity to P. gaudichaudianum essential
oil Fig. 4A), which could indicate the involvement of these path-
ways in the repair of lesion induced by the essential oil. Nerolidol
did not induce increased sensitivity in strains lacking some of the
NER proteins Fig. 4B). Although a previous study reported that ner-
olidol showed pro-oxidant activity (Ruberto et al., 2000), in sup-
port of the sensitivity of the BER strains, the repair pathway
induced by this sesquiterpene seems to be slightly different from
that induced by P. gaudichaudianum essential oil. The complex
composition of the essential oil can explain this difference because
in addition to nerolidol, it also contains other sesquiterpenes, such
as a-humulene (21.32%), bicyclogermacrene (13.16%) and (E)-
caryophyllene (7.51%). Alfa-humulene, e.g., showed cytotoxic
activity on the human prostate carcinoma LNCaP, human prostate
cancer PC-3, adenocarcinomic human alveolar basal epithelial A-
549, colorectal adenocarcinoma DLD-1 and melanoma M4BEU tu-
mor cells and its mechanism of action appears to be associated
with glutathione (GSH) depletion and ROS production (Legault
et al., 2003; Loizzo et al., 2007a).
Interestingly, the double-strand repair defective strains did not
demonstrate pronounced sensitivity to either P. gaudichaudianum
essential oil or nerolidol (Fig. 5), conﬁrming that the essential oil
and nerolidol do not induce double-strand break formation, as
Table 7
Effects of P. gaudichaudianum essential oil and nerolidol on the ROS production in SOD strains.
Treatment Concentration DCF ﬂuorescence (% of control) in SOD-
WT strainc
DCF ﬂuorescence (% of control) in
sod1D strainc
DCF ﬂuorescence (% of control) in
sod2D strainc
NCa 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00
H2O2b 4 mM 141.35 ± 2.83 185.95 ± 9.93 197.55 ± 19.43
P. gaudichaudianum
essential oil
1 lg/mL 105.53 ± 9.58 108.26 ± 16.30 107.21 ± 10.20
10 lg/mL 111.52 ± 12.14 122.81 ± 18.89 110.01 ± 7.62
25 lg/mL 112.88 ± 5.56 124.64 ± 14.24 112.86 ± 0.79
50 lg/mL 115.01 ± 8.01 127.35 ± 1.91 108.45 ± 15.37
100 lg/mL 128.63 ± 5.51 130.74 ± 0.34 119.98 ± 14.94
Nerolidol 1 lg/mL 115.47 ± 10.34 122.56 ± 16.31 109.46 ± 7.01
10 lg/mL 114.45 ± 10.28 137.91 ± 14.23 110.97 ± 6.26
25 lg/mL 123.90 ± 27.27 130.47 ± 11.07 112.95 ± 6.48
50 lg/mL 125.95 ± 2.308 131.51 ± 7.79 125.40 ± 12.09
100 lg/mL 140.21 ± 12.79 173.20 ± 12.59 147.69 ± 7.43
Data are expressed as percentages of control values. Data signiﬁcant in relation to negative control at P < 0.05; P < 0.01 by One Way Anova followed by Dunnett’s Multiple
comparison Test.
a Negative control (solvent; DMSO).
b Positive control: H2O2 treatment at 5 mM.
c Mean and standard deviation of three independent experiments.
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nerolidol.
While the deletion of TLS and PRR proteins had no inﬂuence on
sensitivity to P. gaudichaudianum essential oil, the rev1D, rad30D
and rad18D single mutants exhibited remarkable resistance to ner-
olidol (Fig. 6), suggesting that these pathways can participate in
the cytotoxic potential of nerolidol. Because Rad30 (Pol g) can pro-
mote error-free replication and the Rev1 protein, which functions
in TLS together with Pol f, can act in error-free or error-prone path-
ways (Prakash et al., 2005; Andersen et al., 2008), these results
could explain the absence of mutagenesis in XV185-14c and
N123 strains treated with nerolidol (Tables 4 and 6); however,
more research is needed to afﬁrm that nerolidol enables error-free
TLS.
The sensitivity showed by the ntg1Dntg2Dapn1Drad1D and
ntg1Dntg2Dapn1Drad52Dmutants to P. gaudichaudianum essential
oil (Fig. 7A) is likely to be due to the absence of Ntg2 because when
Ntg2 is absent, the sensitivity increases, which is what occurred
with the single ntg2D and double ntg1Dntg2 mutants. These data
support the involvement of this enzyme in the repair of damage in-
duced by P. gaudichaudianum essential oil. Likewise, the Ntg1 and
Apn1 enzymes appear to be necessary to remove the lesions in-
duced by nerolidol, as the ntg1Dntg2Dapn1Drad52D and
ntg1Dntg2Dapn1Drev3D quadruple mutants showed sensitivity
to nerolidol (Fig. 7B), as did the ntg1D and apn1D single mutants,
the ntg1Dntg2D double mutant and the ntg1Dntg2Dapn1D triple
mutant.
When testing the abilities of P. gaudichaudianum essential oil
and nerolidol to generate ROS, we found that the absence of the
superoxide dismutase enzyme increases the sensitivity to the
essential oil and nerolidol (Fig. 8). This effect was more signiﬁcant
in the sod1D strain after nerolidol treatment (Fig. 8A). The Sod1,
copper- and zinc-containing superoxide dismutases provide the
primary defense against superoxide damage by catalytically
removing it through a disproportionation reaction, which involves
redox cycling at the active copper site (Longo et al., 2008). Addi-
tionally, using the DCF assay, we conﬁrmed that P. gaudichaudia-
num essential oil and nerolidol are able to produce ROS (Table 7),
but the type of ROS produced remains to be determined.
Bakkali et al. (2005, 2006) have demonstrated using yeast as a
model study that ROS and hydrogen peroxide are involved in the
cytotoxic effects as well as in cytoplasmic petite induction (loss
of mitochondria or mitochondrial dysfunction) of essential oils
from different medicinal plants. It has also been demonstrated thatnerolidol decreases HepG2 viability by interfering with the mem-
brane, increasing ROS and decreasing ATP levels (Ferreira et al.,
2012). One possible cytotoxic mechanism to essential oils in gen-
eral involves damage in mitochondrial membranes, changing the
electron ﬂow through the electron transport chain, with increase
in ROS production (Bakkali et al., 2008). Therefore, the decrease
in yeast cell survival shown here could also be related to energy
depletion as consequence of mitochondrial damage. The increase
in ROS which oxidize and damage DNA explains the induction of
single-strand breaks and activation of BER machinery. However,
in the case of P. gaudichaudianum essential oil, if its major recog-
nized mode of action involved ROS formation, resulting in toxic ef-
fect, other mechanisms, including direct DNA ligation or DNA
topoisomerase inhibition should also be investigated, in function
of the sensitivity observed in NER deﬁcient strains.5. Conclusion
This study showed that P. gaudichaudianum essential oil and
nerolidol (a racemic mixture of cis and trans isomers) are not muta-
genic but do induce signiﬁcant cytotoxic effects in Saccharomyces
cerevisiae that are related to ROS generation and the formation of
single-strand breaks. Moreover, trans-nerolidol is the major com-
pound responsible for the biological effects induced by P. gaudi-
chaudianum essential oil.Conﬂict of Interest
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